NovoCure Limited (NVCR) Operating income 2017–2026
NovoCure Limited (NVCR) annual operating income history from SEC filings — each fiscal year as reported.
-$153.8MFY2026 · since FY2017: -$115.3M → -$153.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$153.8M | +9.8% |
| FY2025 | -$170.5M | +26.8% |
| FY2024 | -$232.9M | -160.1% |
| FY2023 | -$89.5M | -101.9% |
| FY2022 | -$44.3M | -245.8% |
| FY2021 | $30.4M | +3426.1% |
| FY2020 | -$914,000 | +97.3% |
| FY2019 | -$33.7M | +14.4% |
| FY2018 | -$39.3M | +65.9% |
| FY2017 | -$115.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice